4-{[5-(4-Chlorophenyl)-1-(4-fluorophenyl)-1H-pyrazol-3-yl]carbonyl}-N-ethylpiperazine-1-carboxamide

被引:1
|
作者
Shahani, Tara [1 ]
Fun, Hoong-Kun [1 ]
Vijayakumar, V. [2 ]
Ragavan, R. Venkat [2 ]
Sarveswari, S. [2 ]
机构
[1] Univ Sains Malaysia, Sch Phys, Xray Crystallog Unit, George Town 11800, Malaysia
[2] VIT Univ, Sch Adv Sci, Organ Chem Div, Vellore 632014, Tamil Nadu, India
关键词
D O I
10.1107/S1600536811023178
中图分类号
O7 [晶体学];
学科分类号
0702 ; 070205 ; 0703 ; 080501 ;
摘要
The asymmetric unit of the title compound, C23H23ClFN5O2, contains two crystallographically independent molecules. In one molecule, the pyrazole ring makes dihedral angles of 43.93 (7) and 35.82 (7)degrees, respectively, with the fluoro-and chloro-substituted benzene rings, while the corresponding angles in the other molecule are 52.26 (8) and 36.85 (7)degrees. The piperazine rings adopt chair conformations. In the crystal, adjacent molecules are connected via intermolecular N-H center dot center dot center dot O, C-H center dot center dot center dot F, C-H center dot center dot center dot N and C-H center dot center dot center dot O hydrogen bonds, forming a two-dimensional network parallel to the bc plane. The crystal structure is further stabilized by a weak pi-pi interaction with a centroid-centroid distance of 3.6610 (8) angstrom and by C-H center dot center dot center dot pi interactions.
引用
收藏
页码:O1747 / U1226
页数:17
相关论文
共 50 条
  • [41] 3-(4-Fluorophenyl)-1-(1-(4-fluorophenyl)-3,3,3-trifluoroprop-1-en-1-yl)-5-fluoro-1H-pyrazole
    Paveliev, Stanislav A.
    Ustyuzhanin, Alexander O.
    Krylov, Igor B.
    Terent'ev, Alexander O.
    MOLBANK, 2023, 2023 (02)
  • [42] 1-[3,5-Bis(4-fluorophenyl)-4,5-dihydro-1H-pyrazol-1-yl]ethanone
    Fun, Hoong-Kun
    Hemamalini, Madhukar
    Samshuddin, S.
    Narayana, B.
    Yathirajan, H. S.
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2010, 66 : O582 - U4734
  • [43] (E)-3-(4-Chlorophenyl)-1-(4-fluorophenyl) prop-2-en-1-one
    Fun, Hoong-Kun
    Chia, Tze Shyang
    Sapnakumari, M.
    Narayana, B.
    Sarojini, B. K.
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2012, 68 : O629 - U1573
  • [44] (E)-1-(4-chlorophenyl)-3-(4-fluorophenyl)prop-2-en-1-one
    Qiu, Xiao-Yang
    Luo, Zhi-Gang
    Yang, Sen-Lin
    Liu, Wei-Sheng
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2006, 62 : O3525 - O3526
  • [45] 1-[3-(4-Fluorophenyl)-5-phenyl-4,5dihydro-1H-pyrazol-1-yl]ethanone
    Fun, Hoong-Kun
    Ooi, Chin Wei
    Sapnakumari, M.
    Narayana, B.
    Sarojini, B. K.
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2012, 68 : O2634 - +
  • [46] 1-[3,5-Bis(4-chlorophenyl)-4,5-dihydro-1H-pyrazol-1-yl]ethanone
    Jasinski, Jerry P.
    Pek, Albert E.
    Samshuddin, S.
    Narayana, B.
    Yathirajan, H. S.
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2010, 66 : O1950 - U619
  • [47] Evaluation of the eutomer of 4-{3-(4-chlorophenyl)-3-hydroxypyrrolidin-1-yl}-1-(4-fluorophenyl)butan-1-one, {(+)-SYA 09}, a pyrrolidine analog of haloperidol
    Ablordeppey, Seth Y.
    Lyles-Eggleston, Margaret
    Bricker, Barbara
    Zhang, Wang
    Zhu, Xue
    Goodman, Carl
    Roth, Bryan L.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (12) : 3219 - 3223
  • [48] 4-[5-(4-Fluorophenyl)-1-(4-phenyl-1,3-thiazol-2-yl)-4,5-dihydro-1H-pyrazol-3-yl]-5-methyl-1-(4-methylphenyl)-1H-1,2,3-triazole
    Abdel-Wahab, Bakr F.
    Ng, Seik Weng
    Tiekink, Edward R. T.
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2013, 69 : O618 - +
  • [49] 4-[5-(4-Fluorophenyl)-3-isopropylisoxazol-4-yl]pyridin-2(1H)-one
    Abadleh, Mohammed
    Peifer, Christian
    Kinkel, Katrin
    Schollmeyer, Dieter
    Laufer, Stefan
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2007, 63 : o1423 - o1425
  • [50] 1-{4-[Bis(4-fluorophenyl)methyl]-piperazin-1-yl}ethanone
    Dayananda, A. S.
    Yathirajan, H. S.
    Keeley, Amanda C.
    Jasinski, Jerry P.
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2012, 68 : O2237 - +